These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 12883692

  • 1. Blockade of her2/neu decreases VEGF expression but does not alter HIF-1 distribution in experimental Wilms tumor.
    Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, O'Toole K, Yamashiro DJ, Kandel JJ.
    Oncol Rep; 2003; 10(5):1271-4. PubMed ID: 12883692
    [Abstract] [Full Text] [Related]

  • 2. Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor.
    Karth J, Ferrer FA, Perlman E, Hanrahan C, Simons JW, Gearhart JP, Rodriguez R.
    J Pediatr Surg; 2000 Dec; 35(12):1749-53. PubMed ID: 11101729
    [Abstract] [Full Text] [Related]

  • 3. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
    Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL.
    Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
    [Abstract] [Full Text] [Related]

  • 4. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
    Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, Yoon SS.
    Cancer Res; 2005 Jul 01; 65(13):5881-9. PubMed ID: 15994966
    [Abstract] [Full Text] [Related]

  • 5. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI, Tumor and Angiogenesis Research Group.
    Cancer; 2002 Sep 01; 95(5):1055-63. PubMed ID: 12209691
    [Abstract] [Full Text] [Related]

  • 6. Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor.
    Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, O'toole K, Yamashiro DJ, Kandel JJ.
    J Pediatr Surg; 2003 Nov 01; 38(11):1569-73. PubMed ID: 14614702
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E.
    Cancer; 2003 Mar 15; 97(6):1573-81. PubMed ID: 12627523
    [Abstract] [Full Text] [Related]

  • 9. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
    Jiang CQ, Fan LF, Liu ZS, Qian Q, Xia D, Diao LM, He YM, Ai ZL.
    Chin Med J (Engl); 2004 Oct 15; 117(10):1541-6. PubMed ID: 15498380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL, Kim WH, Jung J, Cho SJ, Park JW, Kim J, Chung HY, Chang MS, Nam SY.
    Carcinogenesis; 2008 Jan 15; 29(1):44-51. PubMed ID: 17984117
    [Abstract] [Full Text] [Related]

  • 12. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ, Bellamy WT, Briehl MM, Powis G.
    Cancer Res; 2002 Sep 01; 62(17):5089-95. PubMed ID: 12208766
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer.
    Liu LZ, Fang J, Zhou Q, Hu X, Shi X, Jiang BH.
    Mol Pharmacol; 2005 Sep 01; 68(3):635-43. PubMed ID: 15947208
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q, Yang SH, Wang RY, Ye SN, Xia T, Ma DZ.
    Ai Zheng; 2005 May 01; 24(5):531-5. PubMed ID: 15890092
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
    Huang SP, Wu MS, Shun CT, Wang HP, Hsieh CY, Kuo ML, Lin JT.
    J Biomed Sci; 2005 May 01; 12(1):229-41. PubMed ID: 15864753
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
    Chong TW, Horwitz LD, Moore JW, Sowter HM, Harris AL.
    Cancer Res; 2002 Dec 01; 62(23):6924-7. PubMed ID: 12460908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.